The mini-symposium will consist of two parts:

Public Session (14:00–15:15)

This first part is open to a broader audience, including caregivers and family members of patients. The goal is to bridge clinical insights and biological mechanisms in an accessible way.

Expert Session (15:45–18:10)

This expert session brings together leading researchers in omics and neurodegeneration to present and discuss recent advances in the molecular understanding of dementia. Through cutting-edge studies in genomics and epigenomics, the session highlights novel insights into disease mechanisms, biomarkers, and potential therapeutic targets